{"Name":"Cellular Biomedicine Group (CBMG)","perma":"cellular-biomedicine-group-cbmg","BasicInfo":{"funded":"2009-01-01","isClosed":false,"closed":null,"short":"The Cellular Biomedicine Group develops treatments for degenerative and cancerous diseases by utilizing cell therapy technologies."},"FundingRounds":[{"funding_type":"post_ipo_equity","series":null,"announcedDate":"2016-02-05","moneyRaised":43130000},{"funding_type":"venture","series":null,"announcedDate":"2014-04-11","moneyRaised":6907995},{"funding_type":"venture","series":null,"announcedDate":"2013-07-26","moneyRaised":3005006}],"Acquisitions":[{"price":22000000,"paymentType":"cash_and_stock","announcedDate":"2014-08-06","acquireeName":"Agreen Biotech"}],"AcquiredBy":null,"IPO":{"exchange":"NASDAQ","symbol":"CBMG","shares":null,"date":"2007-06-07","openPrice":null,"moneyRaised":null,"valuation":null},"Investments":[],"Products":[],"CurrentTeam":[],"PastTeam":[]}
